Cure My Disease

Don't miss your cure!

 Log in / Sign up

A second chance for the heart: can rehab rewrite the story after shock?

NCT ID NCT06572826

Disease control Sponsor: Fondazione Don Carlo Gnocchi ETS Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 02, 2026 · Last updated Sep 03, 2026 · Updated 1 time

Summary

This study tests whether a structured cardiac rehabilitation program can improve outcomes for people who survived a cardiogenic shock, a life-threatening condition where the heart suddenly fails to pump enough blood. Researchers will enroll 2,000 patients across Italy and compare those who follow the rehab program with those who receive standard care. The program includes tailored exercise, breathing training, and lifestyle guidance. The goal is to see if rehab reduces deaths and hospital readmissions, and improves quality of life and ability to return to work.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Cardiac rehabilitation program including respiratory physiotherapy, muscle strengthening, aerobic training, and lifestyle counseling
What this could lead to
If it works, structured cardiac rehab could become a standard part of recovery after cardiogenic shock, improving survival, reducing hospital readmissions, and helping patients regain function and quality of life.
What could go wrong
This is an observational and interventional study, not a randomized controlled trial, so results may be influenced by patient differences. The benefits of rehab after shock are not yet proven, and participation requires patient commitment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 2,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2024

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All consecutive patients with Cardiogenic Shock (CS) will be included. The deferred consent is admitted for non-competent patients.

Ages

18 to 110 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: • All consecutive patients with a clinical diagnosis of Cardiogenic Shock. Exclusion Criteria: • Refusal to give informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiogenic shock are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiogenic shock Shock, Cardiogenic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiogenic shock

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Fondazione Don Gnocchi

    RECRUITING

    Milan, 20148, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.